Andexanet Alfa Versus 4-Factor PCC for Reversal of Intracranial Hemorrhage Associated With Factor Xa

Gregory Semon, Angela Straughn, Claire Hardman, Barbara Steel, Akpofure Peter Ekeh

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalCritical Care Medicine
Volume49
DOIs
StatePublished - Jan 1 2021

Disciplines

  • Medical Specialties
  • Medicine and Health Sciences
  • Surgery

Cite this